SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-14-298794
Filing Date
2014-08-07
Accepted
2014-08-06 20:04:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 425 d771224d425.htm 425 35688
2 GRAPHIC g771221g02b66.jpg GRAPHIC 13108
3 GRAPHIC g771221g02w54.jpg GRAPHIC 8066
  Complete submission text file 0001193125-14-298794.txt   66901
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Subject) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-14956 | Film No.: 141021403
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE 42ND FLOOR NEW YORK NY 10019 212-813-3700
Pershing Square Capital Management, L.P. (Filed by) CIK: 0001336528 (see all company filings)

IRS No.: 383694136 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425